Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

19.41 -1.16 (-5.61%)
Streaming Delayed Price Updated: 3:18 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 505,035
Open 20.77
Bid (Size) 19.33 (100)
Ask (Size) 19.44 (100)
Prev. Close 20.57
Today's Range 18.94 - 21.00
52wk Range 10.96 - 25.55
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
From CareDx, Inc.
Via Business Wire

Performance

YTD
+1.4%
+1.4%
1 Month
-5.6%
-5.6%
3 Month
+15.7%
+15.7%
6 Month
+55.8%
+55.8%
1 Year
-22.1%
-22.1%

More News

Read More
News headline image
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
4 Analysts Assess CareDx: What You Need To Know ↗
Via Benzinga
News headline image
CareDx President and CEO Sells 19,000 Shares for $412,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Provides Notice of Proposed Derivative Settlement
From CareDx, Inc.
Via Business Wire
News headline image
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
From CareDx, Inc.
Via Business Wire
News headline image
3 Analysts Have This To Say About CareDx ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
CareDx Announces Third Quarter 2025 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Issues Comment Letter on Draft LCD Policy
From CareDx, Inc.
Via Business Wire

Frequently Asked Questions

Is CareDx, Inc. - Common Stock publicly traded?
Yes, CareDx, Inc. - Common Stock is publicly traded.
What exchange does CareDx, Inc. - Common Stock trade on?
CareDx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CareDx, Inc. - Common Stock?
The ticker symbol for CareDx, Inc. - Common Stock is CDNA on the Nasdaq Stock Market
What is the current price of CareDx, Inc. - Common Stock?
The current price of CareDx, Inc. - Common Stock is 19.41
When was CareDx, Inc. - Common Stock last traded?
The last trade of CareDx, Inc. - Common Stock was at 02/11/26 03:18 PM ET
What is the market capitalization of CareDx, Inc. - Common Stock?
The market capitalization of CareDx, Inc. - Common Stock is 1.02B
How many shares of CareDx, Inc. - Common Stock are outstanding?
CareDx, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.